“The failure and mismanagement of other Biobanks for Stem Cell Preservation ruin our sector”, speaks Dr. Luca Mariotta, Scientific Director of SSCB.
Last week, Ticinonews reported on a young couple who were looking for their baby’s cells after the company they had contracted with, Genico, disappeared. Cantonal pharmacist Giovan Maria Zanini said he was concerned about Switzerland’s free-market policy in such a sensitive area.
50,000 stem cell transplants worldwide
More than 50,000 transplants have been performed worldwide using haematopoietic stem cells. Umbilical cord stem cells are multi-potent cells: unspecialised mother cells, capable of self-renewal and of differentiating into different cell types each with specific functions.
Continue readingMusculoskeletal disorders and mesenchymal stem cells
Considered to be one of the leading causes of disability worldwide, musculoskeletal disorders include osteoarthritis, rheumatoid arthritis, low back pain, osteoporosis, sarcopenia and myofascial pain syndrome. There are several clinical studies investigating the efficacy of mesenchymal stem cells in these musculoskeletal disorders (MSDs).
The safety of MSC treatment in humans with osteoarthritis, a chronic inflammatory joint disease, was evaluated in a study of 12 patients. All patients had chronic knee pain. Treatment was performed by intra-articular injection of expanded autologous bone marrow mesenchymal stem cells (BM-MSC).
91% of the patients showed an improvement in cartilage quality.
Furthermore, in another clinical study, some patients were treated with an intra-articular injection of allogeneic BM-MSC (from a donor) and the same results were observed as an increase in cartilage quality.
These results were undoubtedly obtained thanks to the potential of mesenchymal stem cells which, thanks to the microenvironment of the damaged site, expressed key genes in cartilage development and type II collagen synthesis promoting cartilage regeneration.
Fat as a source of stem cells for regenerative and aesthetic medicine
Did you know that SSCB offers you the possibility to store stem cells from fat tissue? Fat tissue is a rich source of stem cells that are widely used in regenerative and aesthetic medicine. But how is fat tissue harvested? The fat is easily and safely harvested through mini-liposuction, which is performed by a doctor.
Thanks to this minimally invasive procedure, you can store your fat and avoid major liposuction or the use of synthetic fillers.
Stem cells: Did you know that there is great compatibility between siblings?
Stem cells are undifferentiated cells that are capable of forming the different cell types that make up an adult individual. Thanks to their ability to differentiate, stem cells are of great interest in various medical fields. Their greater histocompatibility is also interesting, so that this cell type can often be used within families.
The probability of finding a compatible donor outside the family is 0.001 % (1 in 100,000 people). For siblings, on the other hand, the probability of a match is 25 % (1 in 4).
This means that the stem cells of your child that you have stored after birth are very likely to be compatible with the siblings.
Protection SSCB
Protection SSCB is a service dedicated to families who have stored their child’s stem cells with our bio bank. This service was created to provide the child and the whole family with greater security in the event of the sample being returned for a possible transplant.
Continue readingStem Cells from Adipose Tissue
SSCB from this year, thanks also to its GMP (Good Manufacturing Practice) certification, offers a new service to its customers, giving the possibility to store stem cells from adipose tissue for potential future use.
Continue readingNew openings of Zurich and Rome offices
In 2021, SSCB is pleased to announce the opening of new offices in Zurich and Rome, thanks to the achievement of many new milestones, such as the collaboration with the Swiss Stem Cells Foundation (SSCF).
Continue readingStem cell secretome from adipose tissue as a biotherapeutic agent to inhibit growth of triple-negative breast cancer
n this experimental study, a protocol was developed for processing a formulation derived from secretome obtained from adipose tissue mesenchymal stem cells at different concentrations. Its molecular composition and in vitro efficacy was evaluated when applied to breast cancer cell lines. In addition, the ability of the formulation to suppress the growth of triple-negative breast cancer when infused into a mouse model of the disease was verified.
Continue readingIntracerebral infusion of adipose tissue stem cells to treat chronic ischaemic stroke
Current therapies do not induce significant benefits in chronic stroke patients. Preclinical studies suggest that autologous transplantation of adipose tissue stem cells may be of benefit. This phase one clinical trial was developed to test the safety and efficacy of adipose tissue mesenchymal stem transplantation in chronic stroke patients.
Continue reading